James E Besser - Net Worth and Insider Trading
James E Besser Net Worth
The estimated net worth of James E Besser is at least $47,995 dollars as of 2024-12-29. James E Besser is the See Remarks of Processa Pharmaceuticals Inc and owns about 52,665 shares of Processa Pharmaceuticals Inc (PCSA) stock worth over $47,925. James E Besser is also the 10% Owner of Medifirst Solutions Inc and owns about 696,612 shares of Medifirst Solutions Inc (MFST) stock worth over $70. Details can be seen in James E Besser's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that James E Besser has not made any transactions after 2021-04-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of James E Besser
James E Besser Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, James E Besser owns 9 companies in total, including Processa Pharmaceuticals Inc (PCSA) , Minim Inc (MINM) , and SideChannel Inc (SDCH) among others .
Click here to see the complete history of James E Besser’s form 4 insider trades.
Insider Ownership Summary of James E Besser
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PCSA | Processa Pharmaceuticals Inc | 2021-04-08 | 10 percent owner |
| MINM | Minim Inc | 2015-09-25 | 10 percent owner |
| SDCH | SideChannel Inc | 2018-07-24 | 10 percent owner |
 | | 2019-05-01 | 10 percent owner |
| | 2018-11-20 | 10 percent owner |
| | 2013-11-22 | 10 percent owner |
| | 2021-01-15 | 10 percent owner |
| | 2022-06-15 | 10 percent owner |
| | 2022-06-06 | director & other: Director by Deputization |
James E Besser Latest Holdings Summary
James E Besser currently owns a total of 2 stocks. Among these stocks, James E Besser owns 52,665 shares of Processa Pharmaceuticals Inc (PCSA) as of April 8, 2021, with a value of $47,925 and a weighting of 99.85%. James E Besser also owns 696,612 shares of Medifirst Solutions Inc (MFST) as of May 1, 2019, with a value of $70 and a weighting of 0.15%.
Latest Holdings of James E Besser
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PCSA | Processa Pharmaceuticals Inc | 2021-04-08 | 52,665 | 0.91 | 47,925 |
| MFST | Medifirst Solutions Inc | 2019-05-01 | 696,612 | 0.00 | 70 |
Holding Weightings of James E Besser
James E Besser Form 4 Trading Tracker
According to the SEC Form 4 filings, James E Besser has made a total of 4 transactions in Processa Pharmaceuticals Inc (PCSA) over the past 5 years, including 1 buys and 3 sells. The most-recent trade in Processa Pharmaceuticals Inc is the sale of 22,389 shares on April 8, 2021, which brought James E Besser around $5 Million.
According to the SEC Form 4 filings, James E Besser has made a total of 0 transactions in Medifirst Solutions Inc (MFST) over the past 5 years. The most-recent trade in Medifirst Solutions Inc is the acquisition of 96,612 shares on May 1, 2019, which cost James E Besser around $6,763.
Insider Trading History of James E Besser
- 1
James E Besser Trading Performance
GuruFocus tracks the stock performance after each of James E Besser's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by James E Besser is 8.48%. GuruFocus also compares James E Besser's trading performance to market benchmark return within the same time period. The performance of stocks bought by James E Besser within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how James E Besser's insider trading performs compared to the benchmark.
Performance of James E Besser
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -22.34 | | | | | |
| Relative Return to S&P 500(%) | -18.84 | | | | | |
James E Besser Ownership Network
James E Besser Owned Company Details
What does Processa Pharmaceuticals Inc do?
Who are the key executives at Processa Pharmaceuticals Inc?
James E Besser is the 10 percent owner of Processa Pharmaceuticals Inc. Other key executives at Processa Pharmaceuticals Inc include director & 10 percent owner & President & CEO David Young , Chief Business - Strategy Off Patrick Lin , and Chief Executive Officer George K Ng .
Processa Pharmaceuticals Inc (PCSA) Insider Trades Summary
Over the past 18 months, James E Besser made no insider transaction in Processa Pharmaceuticals Inc (PCSA). Other recent insider transactions involving Processa Pharmaceuticals Inc (PCSA) include a net purchase of 41,000 shares made by David Young , a net purchase of 10,000 shares made by George K Ng , and a net purchase of 8,000 shares made by Justin W Yorke .
In summary, during the past 3 months, insiders sold 0 shares of Processa Pharmaceuticals Inc (PCSA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Processa Pharmaceuticals Inc (PCSA) were sold and 63,000 shares were bought by its insiders, resulting in a net purchase of 63,000 shares.
Processa Pharmaceuticals Inc (PCSA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Processa Pharmaceuticals Inc Insider Transactions
James E Besser Mailing Address
Above is the net worth, insider trading, and ownership report for James E Besser. You might contact James E Besser via mailing address: 3 West Hill Place, Boston Ma 02114.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
